PHARMACOKINETIC ANALYSES OF LEDIPASVIR/SOFOSBUVIR IN HCV-INFECTED SUBJECTS WITH ADVANCED LIVER DISEASE AND/OR FOLLOWING LIVER TRANSPLANTATION

被引：0
|
作者：
Garrison, K. L. [1 ]
German, P. [1 ]
Arterburn, S. [1 ]
De-Oertel, S. [1 ]
Brainard, D. [1 ]
Ling, J. [1 ]
Jin, F. [1 ]
Mathias, A. [1 ]
机构：
[1] Gilead, Foster City, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01538-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-198
引用
收藏
页码：S789 / S789
页数：1
相关论文
共 50 条
  • [21] Liver transplantation in HCV-infected patients: An 8 year single center experience
    Nery, JR
    Neff, GW
    Montalbano, M
    Nery, C
    Safdar, K
    Britto, S
    Kato, T
    Levi, D
    Nishida, S
    Madariaga, J
    Bejerano, P
    Ruitz, P
    Schiff, ER
    Tzakis, AG
    JOURNAL OF HEPATOLOGY, 2003, 38 : 45 - 45
  • [22] Aminofeel® improves the sensitivity to taste in patients with HCV-infected liver disease
    Nagao, Yumiko
    Matsuoka, Hisako
    Kawaguchi, Takumi
    Sata, Michio
    MEDICAL SCIENCE MONITOR, 2010, 16 (04): : PI7 - PI12
  • [23] Immunosuppression for liver transplantation in HCV-infected patients: Mechanism-based principles
    Eghtesad, B
    Fung, JJ
    Demetris, AJ
    Murase, N
    Ness, R
    Bass, DC
    Gray, EA
    Shakil, O
    Flynn, B
    Marcos, A
    Starzl, TE
    LIVER TRANSPLANTATION, 2005, 11 (11) : 1343 - 1352
  • [24] NO IMPACT OF OBESITY ON POST-LIVER TRANSPLANTATION OUTCOME AMONG HCV-INFECTED LIVER TRANSPLANT RECIPIENTS
    Torres-Quevedo, R.
    Aguilera, V.
    Rubin, A.
    San Juan, F.
    Moya, A.
    Prieto, M.
    Mir, J.
    Berenguer, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S183 - S183
  • [25] Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients
    Agarwal, Kosh
    Castells, Lluis
    Mullhaupt, Beat
    Rosenberg, William M.
    McNabb, Brian L.
    Arterburn, Sarah
    Camus, Gregory
    McNally, John
    Brainard, Diana M.
    Subramanian, Mani
    Gonsalkorala, Enoka
    Londono, Maria
    Dufour, Jean-Francois
    Forns, Xavier
    HEPATOLOGY, 2017, 66 : 571A - 571A
  • [26] A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis
    Ryan B. Perumpail
    Robert J. Wong
    Edward A. Pham
    John P. Higgins
    Tami J. Daugherty
    Aijaz Ahmed
    Digestive Diseases and Sciences, 2016, 61 : 39 - 41
  • [27] A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis
    Perumpail, Ryan B.
    Wong, Robert J.
    Pham, Edward A.
    Higgins, John P.
    Daugherty, Tami J.
    Ahmed, Aijaz
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (01) : 39 - 41
  • [28] Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients
    Agarwal, Kosh
    Castells, Lluis
    Mullhaupt, Beat
    Rosenberg, William M. C.
    McNabb, Brian
    Arterburn, Sarah
    Camus, Gregory
    McNally, John
    Stamm, Luisa M.
    Brainard, Diana M.
    Subramanian, G. Mani
    Marino, Zoe
    Dufour, Jean-Francois
    Forns, Xavier
    JOURNAL OF HEPATOLOGY, 2018, 69 (03) : 603 - 607
  • [29] SOFOSBUVIR/VELPATASVIR FOR 12 WEEKS IN GENOTYPE 1-4 HCV-INFECTED LIVER TRANSPLANT RECIPIENTS
    Agarwal, Kosh
    Castells, Luis
    Mullhaupt, Beat
    MacDonald, Douglas C.
    McNabb, Brian
    Arterburn, Sarah
    Camus, Gregory
    McNally, John
    Brainard, Diana M.
    Subramanian, G. Mani
    Yip, Christina Sze Man
    Huang, Hai Cheng
    Gonsalkorala, Enoka
    Londono, Maria
    Dufour, Jean-Francois
    Forns, Xavier
    GUT, 2018, 67 : A98 - A99
  • [30] SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE
    Martini, S.
    Strona, S.
    Arese, D.
    Sacco, M.
    Romagnoli, R.
    Tandoi, F.
    Ottobrelli, A.
    Torrani-Cerenzia, M. R.
    Balzola, F.
    Salizzoni, M.
    Rizzetto, M.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E55 - E55
12345